XANTHUS LIFE SCIENCES INC

Overview

Total Patents

27

About

XANTHUS LIFE SCIENCES INC has a total of 27 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and micro-structure and nano-technology are TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INST OF GERONTOLOGY, OXFORD GLYCOSCIENCES UK LTD and CAI JIANPING.

Map
Trends
Similars
Markets
Inventors
List

Patent filings in countries

World map showing XANTHUS LIFE SCIENCES INCs patent filings in countries

#	Country	Total Patents
#1	United States	11
#2	Australia	6
#3	WIPO (World Intellectual Property Organization)	5
#4	Canada	2
#5	EPO (European Patent Office)	2
#6	Japan	1

Patent filings per year

Chart showing XANTHUS LIFE SCIENCES INCs patent filings per year from 1900 to 2020

Similar Companies

TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INST OF GERONTOLOGY 92% similarity

OXFORD GLYCOSCIENCES UK LTD 92% similarity

CAI JIANPING 92% similarity

SAHLTECH I GOTEBORG AB 91% similarity

RHEOSCIENCE AS 91% similarity

LIFE AND BRAIN GMBH 90% similarity

GLIMCHER LAURIE H 90% similarity

SENEX BIOTECHNOLOGY INC 90% similarity

METAFORA BIOSYSTEMS 90% similarity

PROTEOSYS AG 90% similarity

Focus industries

#	Industry
#1	Pharmaceuticals
#2	Measurement
#3	Micro-structure and nano-technology
#4	Biotechnology
#5	Organic fine chemistry

Focus technologies

#	Technology
#1	Analysing materials
#2	Nanostructure applications
#3	Heterocyclic compounds
#4	Measuring microorganism processes
#5	Therapeutic chemical compounds
#6	Medical preparations
#7	Peptides

Top inventors

#	Name	Total Patents
#1	Leyland-Jones Brian	14
#2	Ajami Alfred M	13
#3	Barlow David O	4
#4	Barlow David	3
#5	Fink Mitchell P	3
#6	Sims Carrie A	3

Latest patents

Publication	Filing date	Title
US2005239816A1	2005-06-29	Amonafide salts
US2005059738A1	2004-09-23	Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
AU2003280262A1	2003-06-27	Individualization of therapy with anticoagulants
WO03052123A1	2002-12-18	Individualization of therapy with antihistamines
AU2002351594A1	2002-12-18	Elisa kit for cyp 2c9 metabolic phenotypes
AU2002342488A1	2002-11-27	Individualization of therapy with anesthetics
US2004101477A1	2002-11-27	Individualization of therapy with anesthetics
AU2002349225A1	2002-11-27	Individualization of therapy with antiviral agents
US2003203932A1	2002-04-22	Amonafide salts
AU8000500A	2000-10-06	Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
US6740305B1	2000-04-10	Assessment of gastric emptying disorders
CA2369484A1	2000-04-10	Assessment of gastric emptying disorders